TARDBPP1

Across TCGA pan-cancer cohorts, TARDBPP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TARDBPP1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where TARDBPP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TARDBPP1 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

BRCA, THCA, and LUSC are the cancer types where TARDBPP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TARDBPP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.029	.037	4	view →
THCA	All	All	−0.007	.016	2	view →
LUSC	Male	All	−0.009	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

TARDBPP1–BRCA

Open the BRCA breakdown →